1-[5,6-二氢-4-[[4-(4-羟基-1-哌啶基)苯基]氨基]-5-氧代嘧啶并[4,5-d]哒嗪-2-基]-4-哌啶乙腈
1-[5,6-Dihydro-4-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5-oxopyrimido[4,5-d]pyridazin-2-yl]-4-piperidineacetonitrile
2-(1-(4-((4-(4-羟基哌啶-1-基)苯基)氨基)-5-氧代-5,6-二氢嘧啶并[4,5-d]哒嗪-2-基)哌啶-4-基)乙腈 2-(1-(4-((4-(4-羟基哌啶-1-基)苯基)氨基)-5-氧代-5,6-二氢嘧啶并[4,5-d]哒嗪-2-基)哌啶-4-基)乙腈 展开
1425381-60-7
C16H33NO2
271.4
中文名称 1-[5,6-二氢-4-[[4-(4-羟基-1-哌啶基)苯基]氨基]-5-氧代嘧啶并[4,5-d]哒嗪-2-基]-4-哌啶乙腈
中文别名 2-(1-(4-((4-(4-羟基哌啶-1-基)苯基)氨基)-5-氧代-5,6-二氢嘧啶并[4,5-d]哒嗪-2-基)哌啶-4-基)乙腈
英文名称 1-[5,6-Dihydro-4-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5-oxopyrimido[4,5-d]pyridazin-2-yl]-4-piperidineacetonitrile
英文别名 Gusacitinib;Gusacitinib [INN];gusacitinib (proposed INN);ASN002;GTPL10000;4801QYW816;example 189 [WO2013028818A1];4-Piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-;ASN-002;2-(1-(4-((4-(4-Hydroxypiperidin-1-yl)phenyl)amino)-5-oxo-5,6-dihydropyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile;Gusacitinib [USAN];EN-3351;UNII-4801QYW816;AKOS040741172;EN3351;BCP31675;Gusacitinib (ASN-002)?;NSC-818003;SCHEMBL14717111;2-[1-(4-{[4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5-oxo-3H-pyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl]acetonitrile;CHEMBL4594275;HY-103018;F78024;Gusacitinib [USAN:INN];1425381-60-7;1-(4-(4-(4-Hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-D)pyridazin-2-yl)-piperidin-4-YL-acetonitrile;2-(1-(4-(4-(4-Hydroxypiperidin-1-yl)phenylamino)-5-oxo-5,6-dihydropyrimido[5,4-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile;GUSACITINIB [WHO-DD];D11676;WHO 10976;NSC818003;DB-133043;ASN-002; ASN 002; ASN002;BDBM50595921;CS-0023113;2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile;EX-A2668;MS-28452;Gusacitinib (USAN/INN)
CAS No. 1425381-60-7
分子式 C16H33NO2
分子量 271.40
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS